You are here

American Hospital Association Offers Value-Based Care Advice

New report tells post-acute care providers what they need to know

A new TrendWatch report from the American Hospital Association (AHA) says that post-acute care (PAC) providers play a key role in the transition from volume-based to value-based care.

In recent years, larger percentages of Medicare patients are being discharged to PAC settings, according to a FiereceHealthcare article on the report. For example, 17.3% were discharged to skilled nursing facilities in 2008, compared to 19.5% in 2013.

The increased proliferation of alternative payment models that involve shared risk among hospitals, PAC providers, and insurers means PAC providers must understand factors such as geographic PAC spending variation. This variation is due to several drivers, including broad variation in conditions, comorbidities, and medical severity; volume of patients discharged to PAC settings after short stays in acute hospital settings; and the amount and category of PAC services received during the care episode.

Major PAC providers have already made strides in improving or creating business models to make them better suited to a value-based care system. For example, RML Specialty Hospital, a Chicago long-term care hospital, focuses its accountable care organization’s  resources on highly-specialized care for patients admitted directly from a hospital who needed three days in an intensive care unit. RML also has joined multiple PAC continuing care networks, and is currently tracking data on patients discharged from the hospital for 180 days, which it will then use to compare the outcomes to those of patients discharged from other types of post-acute providers.

Source: FierceHealthcare, December 22, 2015.

Recent Headlines

Almost 64% of Patients Showed Decreased Hemoglobin A1c Levels
Lifesaving Life Foam for Battlefield, Terrorist Attacks, Trauma
Cell Reprogramming Process May Benefit Patients Prone to Severe Hypoglycemia
Beagles Beat Out Advanced Technology
Over Half of Patients Had Reduced Pain Levels of 30% or More
Spina Bifida, Cleft Lip Among Defects Caused by Antiepilectics
Study Data Indicate Drug May Provide Complete Remission in PV
Teplizumab Slows Progression to Disease by at Least Two 2 Years
First Anti-PD-1 Therapy Demonstrates Improved Overall Survival